Peter Vijn Selected Research

2-(N-bis(2-methoxyethyl)amino)butyric acid,2',6'-dimethoxyphenyl ester hydrobromide

6/2010

First administration to man of Org 25435, an intravenous anaesthetic: A Phase 1 Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Vijn Research Topics

Disease

1	Tachycardia (Tachyarrhythmias) 06/2010
1	Hypotension (Low Blood Pressure) 06/2010
1	Hypersensitivity (Allergy) 01/2010
1	Inflammation (Inflammations) 01/2010
1	Arthritis (Polyarthritis) 01/2010
1	Experimental Arthritis 01/2010

Drug/Important Bio-Agent (IBA)

1	Pharmaceutical PreparationsIBA 06/2010
1	2-(N-bis(2-methoxyethyl)amino)butyric acid,2',6'-dimethoxyphenyl ester hydrobromideIBA 06/2010
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 01/2010
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2010
1	Estrogen Receptor alphaIBA 01/2010
1	Estrogen Receptor betaIBA 01/2010
1	Estrogens (Estrogen)FDA Link 01/2010